Phakellistatin 10

General Information


DRACP ID  DRACP02938

Peptide Name   Phakellistatin 10

Sequence  IPYVPLTP

Sequence Length  8

UniProt ID  Not available

PubChem CID  44584154 

Origin  Phakellia sp.

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
P388 Mouse lymphoma Lymphoma ED50=2.1 µg/ml Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02938

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Glu1<--->Pro8

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C45H70N8O11

Absent amino acids  ACDEFGHKMNQRSW

Common amino acids  P

Mass  102413

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  1117

Hydrophobicity  71.25

Aliphatic Index  133.75

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  212.86

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 7673945

Title  Antineoplastic agents, 325. Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 from Phakellia sp

Doi 10.1021/np50120a025

Year  1995

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.